[DEVELOPMENT AND CHALLENGES OF ANNULUS FIBROSUS TISSUE ENGINEERING].
Summary
Annulus fibrosus tissue engineering shows promise for intervertebral disc repair. Mesenchymal stem cells and composite biomaterials are key to regenerating annulus fibrosus tissue for clinical applications.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedics
Background:
- The annulus fibrosus is crucial for intervertebral disc function.
- Degeneration of the annulus fibrosus leads to disc disease.
- Current treatments for annulus fibrosus damage are limited.
Purpose of the Study:
- To review the biomaterial and clinical prospects of annulus fibrosus tissue engineering.
- To summarize current advancements in cell sources, bioactive molecules, and biomaterials for annulus fibrosus regeneration.
Main Methods:
- Extensive literature review of annulus fibrosus tissue engineering.
- Analysis of cell sources, including mesenchymal stem cells (MSCs).
- Evaluation of bioactive molecules and biomaterial properties.
Main Results:
- Mesenchymal stem cells (MSCs) are ideal seed cells for annulus fibrosus repair.
- A 2:1 ratio of annulus fibrosus cells to MSCs optimizes mRNA expression.
- Bioactive molecules (growth factors, morphogens, etc.) promote extracellular matrix synthesis and disc homeostasis.
- Composite biomaterials offer a promising trend for scaffold development, though optimal materials require further study.
Conclusions:
- Annulus fibrosus tissue engineering holds significant potential for annulus fibrosus regeneration and repair.
- This field offers broad prospects for future clinical applications in treating disc degeneration.
